Not only the type of TP53 mutation determines the tumor spectrum and severity of phenotype, but other germline genetic factors such as polymorphisms for TP53 and MDM2[10] and telomere length [11,12] are assumed to modulate the cancer phenotype. The gene discussed is TP53; the disease is neoplasm.